In this edition of Bloomberg Intelligence’s Votes & Verdicts podcast, Aude Gerspacher, BI’s senior litigation analyst, and Duane Wright, senior health care policy analyst, discuss the first results of the US government’s Medicare price negotiations, its implications and the outlook for the next list of drugs to be negotiated.

<p>In this edition of Bloomberg Intelligence’s Votes &amp; Verdicts podcast, Aude Gerspacher, BI’s senior litigation analyst, and Duane Wright, senior health care policy analyst, discuss the first results of the US government’s Medicare price negotiations, its implications and the outlook for the next list of drugs to be negotiated.</p>

Votes and Verdicts is a series that examines the intersection of business, policy and law. It features conversations between Bloomberg Intelligence's team of litigation and policy analysts and thought leaders discussing legal and policy issues affecting markets and business decisions across many sectors.

<p>Votes and Verdicts is a series that examines the intersection of business, policy and law. It features conversations between Bloomberg Intelligence's team of litigation and policy analysts and thought leaders discussing legal and policy issues affecting markets and business decisions across many sectors.</p>

Votes & Verdicts

Medicare’s First Negotiated Price List Is Here

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/8e777911-f569-4a03-8d39-b1d900ceacdd/transcript

Advertisement